| human | Q5 |
| P496 | ORCID iD | 0000-0002-3413-2189 |
| P108 | employer | Phillip T. and Susan M. Ragon Institute | Q7185824 |
| P106 | occupation | researcher | Q1650915 |
| Q92312862 | Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers |
| Q35803583 | Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study |
| Q42236997 | Association of adiponectin (ADIPOQ) rs2241766 polymorphism and dyslipidemia in HIV/HCV-coinfected patients |
| Q55349380 | Correction: Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women. |
| Q31045563 | Dendronized Anionic Gold Nanoparticles: Synthesis, Characterization, and Antiviral Activity |
| Q58615808 | Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status |
| Q91496242 | Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile |
| Q36967950 | Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen |
| Q40174105 | Efficacy of carbosilane dendrimers with an antiretroviral combination against HIV-1 in the presence of semen-derived enhancer of viral infection |
| Q50042453 | Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/HCV-coinfected patients |
| Q92211046 | European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study |
| Q52580522 | Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women. |
| Q34474404 | FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients |
| Q40135804 | G2-S16 dendrimer as a candidate for a microbicide to prevent HIV-1 infection in women |
| Q96118148 | Hiv Controllers Maintain Viral Suppression Despite Waning T-Cell Responses On Art |
| Q40984077 | IL7RA polymorphisms predict the CD4+ recovery in HIV patients on cART. |
| Q98902954 | Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19 |
| Q90484655 | Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study |
| Q98470402 | Near normalization of peripheral blood markers in HIV-infected patients on long-term suppressive antiretroviral therapy: a case-control study |
| Q40734101 | Optimal vitamin D plasma levels are associated with lower bacterial DNA translocation in HIV/hepatitis c virus coinfected patients. |
| Q34803775 | PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study |
| Q47258805 | Pegylated IFN-α-induced NK cell activation is associated with HIV-1 DNA decline in ART-treated HIV-1/HCV co-infected patients. |
| Q96685910 | Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study |
| Q42288458 | Prediction of hepatic fibrosis in patients coinfected with HIV and hepatitis C virus based on genetic markers |
| Q36926843 | Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action. |
| Q42238889 | SLC30A8 rs13266634 polymorphism is related to a favorable cardiometabolic lipid profile in HIV/hepatitis C virus-coinfected patients. |
| Q98189888 | The Loss of Bcl-6 Expressing T Follicular Helper Cells and the Absence of Germinal Centers in COVID-19 |
| Q35142495 | rs7903146 polymorphism at transcription factor 7 like 2 gene is associated with total cholesterol and lipoprotein profile in HIV/hepatitis C virus-coinfected patients |
Search more.